home / stock / rgbpp / rgbpp quote
Last: | $1.95 |
---|---|
Change Percent: | 100.0% |
Open: | $0 |
Close: | $1.95 |
High: | $0 |
Low: | $0 |
Volume: | 6 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$1.95 | $0 | $1.95 | $0 | $0 | 6 | 05-02-2024 |
$1.95 | $0 | $1.95 | $0 | $0 | 41 | 05-01-2024 |
$1.95 | $0 | $1.95 | $0 | $0 | 4 | 04-30-2024 |
$1.95 | $0 | $1.95 | $0 | $0 | 13 | 04-29-2024 |
$1.95 | $0 | $1.95 | $0 | $0 | 2 | 04-26-2024 |
$1.95 | $1.95 | $1.95 | $1.95 | $1.95 | 546 | 04-25-2024 |
$3.2 | $0 | $3.2 | $0 | $0 | 1 | 04-24-2024 |
$3.2 | $0 | $3.2 | $0 | $0 | 2 | 04-22-2024 |
$3.2 | $0 | $3.2 | $0 | $0 | 3 | 04-19-2024 |
$3.2 | $0 | $3.2 | $0 | $0 | 1 | 04-18-2024 |
$3.2 | $0 | $3.2 | $0 | $0 | 1 | 04-16-2024 |
$3.2 | $3.2 | $3.2 | $3.2 | $3.2 | 190 | 04-12-2024 |
$3.2 | $3.2 | $3.2 | $3.2 | $3.2 | 154 | 04-11-2024 |
$3.2 | $3.2 | $3.2 | $3.2 | $3.2 | 397 | 04-10-2024 |
$2.15 | $2.15 | $2.15 | $2.15 | $2.15 | 150 | 04-08-2024 |
$3.2 | $3.2 | $3.2 | $3.2 | $3.2 | 115 | 04-05-2024 |
$3.52 | $3.2 | $3.52 | $3.52 | $3.2 | 486 | 04-04-2024 |
$3.2 | $0 | $3.2 | $0 | $0 | 125 | 04-03-2024 |
$3.2 | $2.02 | $3.2 | $3.2 | $2.02 | 834 | 04-02-2024 |
$2.02 | $0 | $2.02 | $0 | $0 | 4 | 04-01-2024 |
News, Short Squeeze, Breakout and More Instantly...
Regen BioPharma Company Name:
RGBPP Stock Symbol:
OTCMKTS Market:
SAN DIEGO, Nov. 16, 2023 /PRNewswire/ -- Regen BioPharma, Inc. (OTC:RGBP) (OTC:RGBPP) The Company has announced that after interviewing several ca...
Regen BioPharma, Inc. Selects Contract Research Organization to Assist in DuraCAR Experiments PR Newswire SAN DIEGO , Nov. 16, 2023 /PRNewswire/ -- Regen BioPharma, Inc. (OTC PINK: RGBP) (OTC PINK: RGBPP) The Company has announced that after interviewing sev...
Regen BioPharma, Inc. CEO Outlines Future Steps in CAR T Program PR Newswire SAN DIEGO , Nov. 14, 2023 /PRNewswire/ -- Regen BioPharma, Inc. (OTC PINK: RGBP) (OTC PINK: RGBPP) has previously discussed initiation of its DuraCAR CAR T-cell therapeutic ( http...